<DOC>
	<DOCNO>NCT00354367</DOCNO>
	<brief_summary>To investigate clinical efficacy certolizumab pegol fistula closure Crohn 's disease subject active drain fistula .</brief_summary>
	<brief_title>Evaluate Efficacy Certolizumab Crohn 's Patients With Draining Fistulas</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Patients single multiple fistula , include perianal enterocutaneous fistula least 3 month complication Crohn 's disease Symptomatic obstructive intestinal stricture , bowel resection , proctocolectomy total colectomy , abscesses present screening , current total parenteral nutrition , short bowel syndrome . All concomitant disease pathological condition could interfere Crohn 's disease assessment harmful well patient . Previous clinical trial previous biological therapy could interfere result present clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Crohn Disease</keyword>
	<keyword>Certolizumab pegol</keyword>
	<keyword>Fistula</keyword>
</DOC>